Navigation Links
Novo Nordisk Supports Three Houston-Based Organizations In Fight Against Diabetes
Date:9/13/2012

HOUSTON, Sept. 13, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that it has awarded $60,000 in sponsorships to three Houston community organizations. The Houston sponsorships are part of the nationwide Novo Nordisk Community Care initiative to help rally communities to address the diabetes crisis and support local programs designed to make an impact for people living with type 2 diabetes. According to data commissioned by Novo Nordisk from the Institute of Alternative Futures, as of 2010, Houston had 804,600 people with diagnosed and undiagnosed diabetes and an additional 1.5 million in danger of developing diabetes.

Novo Nordisk convened a panel of local diabetes experts and community leaders to help evaluate the many innovative programs that were presented for sponsorship. The panel comprised of Dr. Nicole Hare-Everline, Wellness Director for the City of Houston; Lourdes Cuellar, Director of Pharmacy at Memorial Hermann; Dr. Adlia Ebeid, Program Director at Texas Southern University Pharmacy School; Dr. Kevin McKinney, UTMB Professor of Internal Medicine, and Ralston Creswell, Senior Executive Director of ADA Houston. Programs that received funding were considered to be the most creative, impactful, and meaningful for the community and took an innovative approach to addressing the problem of type 2 diabetes.  

"We know from research that type 2 diabetes has far-reaching impact in our city and that local Houston organizations play a critical role in addressing the problem through programs that tap into understanding of the local population," said Dr. Nicole Hare-Everline. "By providing support to incubate innovative programs on a local level, Novo Nordisk is providing an important resource to help address the diabetes epidemic in Houston."

Organizations that received sponsorships target a range of diverse communities in Houston and include:

  • Asian American Health Coalition (HOPE Clinic): The health clinic, located in southwest Houston, plans to partner with the University of Houston School of Pharmacy to conduct an educational program that reaches Asian Americans.
  • Harris County Hospital District Foundation: With the sponsorship, they plan to lead a multidisciplinary nurse lead diabetes management program for patients with uncontrolled diabetes.
  • Lighthouse of Houston: The organization plans to provide specialized education and diabetes self-management training to help reduce diabetes related complications.

"Novo Nordisk is proud to partner with each of these Houston organizations for their innovative approach to diabetes education in their local community," said Lori Moore, Executive Director of Communications and Public Affairs at Novo Nordisk. "It is our hope that through Community Care, Novo Nordisk can help local organizations around the country develop impactful programs that will have a lasting effect on the epidemic of type 2 diabetes."

In 2011, Novo Nordisk Community Care sponsored more than 20 diverse community-based programs and awarded $415,000 to organizations in Atlanta, Minneapolis, Boston, and Philadelphia. In 2012, Novo Nordisk is also offering new sponsorship opportunities to eligible organizations in the San Francisco and Detroit metropolitan areas where diabetes is a heavy burden on the community. In these areas, the Novo Nordisk Community Care initiative aims to activate and enable organizations that are ambassadors for change in diabetes care and are making an impact in their local communities. For more information about Novo Nordisk Community Care, visit www.novonordisk-us.com/communitycare.

About Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk-us.com.


'/>"/>
SOURCE Novo Nordisk
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
2. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
3. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
4. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
5. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
6. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
7. Ventana Supports World Patient Safety Day, July 25
8. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
9. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
10. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
11. Henry Schein Cares Supports Alliance for Oral Health Across Borders Leadership Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):